98%
921
2 minutes
20
Background: Illicit substance use (ISU) may be a potential predisposing factor for severe COVID-19 outcomes.
Objective: To conduct a propensity score-matching analysis to assess and compare the mortality rate of individuals who reported ISU among a sizable cohort of hospitalized COVID-19 patients in Brazil.
Methods: This population-based retrospective cohort study analyzed a nationwide Brazilian database of patients hospitalized for COVID-19. Eligible patients were aged >18 years and tested positive for SARS-CoV-2 infection. The primary exposure of interest was ISU, defined as substances prohibited under Brazilian law, primarily marijuana, cocaine, and crack. Statistical analysis was performed using t-tests, chi-square tests, the Propensity Score Matching (PSM) technique to create a balanced comparison group, and the McNemar test for paired samples to assess mortality risk among patients with ISU.
Results: In a cohort of 2,124,285 patients, 1,845 had ISU. The mortality rate in the ISU group was slightly higher than that in the non-ISU group (33% vs. 32%). After PSM, we found a higher odds ratio for death in patients with ISU (OR 2.18; 95% CI 1.85-2.57; < 0.001).
Conclusion: Our study highlights a significant association between ISU and an increased mortality risk in COVID-19 patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10826084.2025.2465978 | DOI Listing |
JMIR Res Protoc
September 2025
University of Nevada, Las Vegas, Las Vegas, NV, United States.
Background: In-hospital cardiac arrest (IHCA) remains a public health conundrum with high morbidity and mortality rates. While early identification of high-risk patients could enable preventive interventions and improve survival, evidence on the effectiveness of current prediction methods remains inconclusive. Limited research exists on patients' prearrest pathophysiological status and predictive and prognostic factors of IHCA, highlighting the need for a comprehensive synthesis of predictive methodologies.
View Article and Find Full Text PDFBlood Adv
September 2025
AP-HP, Hôpital Saint Louis and University of Paris, INSERM U944 and THEMA insitute, Paris, France.
Germline DDX41 mutations (DDX41mut) are identified in approximately 5% of myeloid malignancies with excess of blasts, representing a distinct MDS/AML entity. The disease is associated with better outcomes compared to DDX41 wild-type (DDX41WT), but patients who do not undergo allogeneic hematopoietic stem cell transplantation (HSCT) may experience late relapse. Due to the recent identification of DDX41mut, data on post-HSCT outcomes remain limited.
View Article and Find Full Text PDFCrit Care Explor
September 2025
Department of Biostatistics, University of Florida Colleges of Medicine and Public Health and Health Professions, Gainesville, FL.
Objectives Background: Monocyte anisocytosis (monocyte distribution width [MDW]) has been previously validated to predict sepsis and outcome in patients presenting in the emergency department and mixed-population ICUs. Determining sepsis in a critically ill surgical/trauma population is often difficult due to concomitant inflammation and stress. We examined whether MDW could identify sepsis among patients admitted to a surgical/trauma ICU and predict clinical outcome.
View Article and Find Full Text PDFBJS Open
September 2025
Digestive Surgery and Transplantation Department, Toulouse University Hospital Centre, Toulouse, France.
Background: Intraoperative autotransfusion remains underutilized in high-risk haemorrhagic oncological procedures, particularly in liver transplantation for hepatocellular carcinoma. This is because of the theoretical risk of tumour cell reinfusion and dissemination, potentially leading to reduced recurrence-free survival. The aim of this study was to evaluate the impact of intraoperative autotransfusion on recurrence-free survival during liver transplantation for hepatocellular carcinoma.
View Article and Find Full Text PDF